Brief: Brainsway Ltd Says Israeli Ministry Of Health Has Approved Coverage Applicable To Its Deep TMS System For Treatment Of Depression
28/06/2022 13:10
June 28 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY LTD - ISRAELI MINISTRY OF HEALTH HAS APPROVED
COVERAGE
APPLICABLE TO ITS DEEP TMS SYSTEM FOR TREATMENT OF DEPRESSION
Source text for Eikon: ID:nGNX4w6wB4
Further company coverage: BWAY.TA
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)